Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Great Portland Estates sees strong leasing demand in fourth quarter

(Sharecast News) - Great Portland Estates has hailed a strong end to its financial year, with leases around 10% above estimates in the fourth quarter, as the London-based real estate group saw solid demand for its fully managed properties. Some 32 new leases and renewals were signed during the three months to 31 March in what GPE called "one of our busiest quarters on record". These new deals generated annual rent of £18.2m with market lettings on average 9.9% ahead of the estimated rental value (ERV) at the start of the financial year.

For the full year, 74 new leases and renewals were signed, generating £37.7m in annual rent at 10.6% above ERV, 41 of which were fully managed.

Net operating income (NOI) for GPE's fully managed sites totalled £16m, up 60% since its interim results were released.

"At the outset of the financial year, we set ourselves ambitious targets for creating and leasing new fully managed spaces. As the year comes to a close, the GPE team has delivered on this ambition with our NOI up 60% since November," said chief executive Toby Courtauld.

Courtauld said that good progress across GPE's development pipeline and strong demand means it is "well positioned to take full advantage of favourable leasing markets".

He added: "Despite the volatile macro-economic backdrop, a supportive surplus of demand over supply in our local markets gives us confidence in our positive rental growth and TAR [total accounting return] outlook."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.